JPH11172246A - Anti-oxidant and manufacture thereof - Google Patents
Anti-oxidant and manufacture thereofInfo
- Publication number
- JPH11172246A JPH11172246A JP9350215A JP35021597A JPH11172246A JP H11172246 A JPH11172246 A JP H11172246A JP 9350215 A JP9350215 A JP 9350215A JP 35021597 A JP35021597 A JP 35021597A JP H11172246 A JPH11172246 A JP H11172246A
- Authority
- JP
- Japan
- Prior art keywords
- peroxynitrite
- derived
- antioxidant
- plant
- protein damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 45
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 37
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 235000006708 antioxidants Nutrition 0.000 title abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- 230000006378 damage Effects 0.000 claims abstract description 32
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000018102 proteins Nutrition 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 25
- 230000000694 effects Effects 0.000 claims abstract description 19
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- -1 methoxyl group Chemical group 0.000 claims abstract description 15
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 9
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 9
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 9
- 240000008042 Zea mays Species 0.000 claims abstract description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 9
- 235000005822 corn Nutrition 0.000 claims abstract description 9
- 241000533293 Sesbania emerus Species 0.000 claims abstract description 7
- 108010068370 Glutens Proteins 0.000 claims abstract description 4
- 235000021312 gluten Nutrition 0.000 claims abstract description 4
- 235000012054 meals Nutrition 0.000 claims abstract description 4
- 240000006365 Vitis vinifera Species 0.000 claims abstract 4
- 230000002401 inhibitory effect Effects 0.000 claims description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 abstract description 16
- 235000013305 food Nutrition 0.000 abstract description 12
- 239000000284 extract Substances 0.000 abstract description 9
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 230000004792 oxidative damage Effects 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 3
- 230000003449 preventive effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 208000014674 injury Diseases 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- 210000003617 erythrocyte membrane Anatomy 0.000 description 9
- 235000010384 tocopherol Nutrition 0.000 description 9
- 239000011732 tocopherol Substances 0.000 description 9
- 229960001295 tocopherol Drugs 0.000 description 9
- 229930003799 tocopherol Natural products 0.000 description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 9
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 239000011668 ascorbic acid Substances 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- 241000219095 Vitis Species 0.000 description 5
- 239000000469 ethanolic extract Substances 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 238000006388 chemical passivation reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- GIANIJCPTPUNBA-QMMMGPOBSA-N (2s)-3-(4-hydroxyphenyl)-2-nitramidopropanoic acid Chemical compound [O-][N+](=O)N[C@H](C(=O)O)CC1=CC=C(O)C=C1 GIANIJCPTPUNBA-QMMMGPOBSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- FBTSQILOGYXGMD-LURJTMIESA-N 3-nitro-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C([N+]([O-])=O)=C1 FBTSQILOGYXGMD-LURJTMIESA-N 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
【0001】[0001]
【0002】本発明は、生体傷害の抑制作用を有する植
物由来の抗酸化物質及びその製造方法に関する。[0002] The present invention relates to a plant-derived antioxidant having a biological injury suppressing action and a method for producing the same.
【0003】[0003]
【0004】従来、抗酸化物質として、天然由来の物質
がいくつか報告されているが、この天然由来の抗酸化物
質の利用目的は、主に食品や化粧品の酸化防止という点
にあった。Heretofore, some naturally occurring substances have been reported as antioxidants, but the purpose of utilizing these naturally occurring antioxidants was mainly to prevent oxidation of foods and cosmetics.
【0005】また近年、生体における酸化傷害が様々な
疾病に関与することが示唆されるにいたり、抗酸化物質
が疾病の予防に有効であるとの報告もされつつある。[0005] In recent years, it has been suggested that oxidative damage in living bodies is involved in various diseases, and it has been reported that antioxidants are effective in preventing diseases.
【0006】しかしながら、これまでに見い出された多
くの植物由来の抗酸化物質、例えば、特開平2−193
930号公報、特開平6−128138号公報に記載の
ものは、食品の酸化防止や化粧品の美白作用という点
で、従来から使われているトコフェロール、アスコルビ
ン酸といったものに比べ抗酸化活性が顕著ではなく、様
々な問題により、十分な実用化には至っていない。However, many plant-derived antioxidants which have been found so far, for example, Japanese Patent Application Laid-Open No. 2-193
No. 930 and JP-A-6-128138 have a remarkable antioxidant activity as compared with conventionally used tocopherol and ascorbic acid in terms of antioxidation of foods and whitening action of cosmetics. However, due to various problems, it has not yet been sufficiently commercialized.
【0007】そのため、従来から抗酸化物質として使わ
れているトコフェロール、アスコルビン酸と同様に、食
品の酸化防止や化粧品の美白作用について満足できる程
度の効果を有し、しかも、生体における活性酸素による
酸化傷害に対しても、十分な抑制効果を有するものが望
まれていた。[0007] Therefore, like tocopherol and ascorbic acid, which have been conventionally used as antioxidants, they have a satisfactory effect on the prevention of food oxidation and the whitening effect of cosmetics, and furthermore, the oxidation by active oxygen in living organisms. What also has the sufficient inhibitory effect also with respect to the injury was desired.
【0008】[0008]
【0009】本発明者らは、上記課題を克服するため鋭
意研究を行い、最近になりペルオキシナイトライトによ
り選択的に生成する3−ニトロチロシンが、様々な病巣
において存在することを知るに至り、生体における新た
な過酸化物としてペルオキシナイトライトに着目した。The present inventors have conducted intensive studies to overcome the above-mentioned problems, and have recently found that 3-nitrotyrosine selectively produced by peroxynitrite is present in various lesions. We focused on peroxynitrite as a new peroxide in living organisms.
【0010】そして、本発明者らは更に研究を進めた結
果、ペルオキシナイトライトによるコラーゲンの酸化傷
害の抑制作用は、従来の抗酸化物質であるトコフェロー
ル、アスコルビン酸、BHAなどには殆ど見られないの
に対し、いくつかの植物由来の抗酸化物質には見られる
ことを見い出した。As a result of further studies by the present inventors, the inhibitory effect of peroxynitrite on the oxidative damage of collagen is hardly found in conventional antioxidants such as tocopherol, ascorbic acid and BHA. In contrast, we found that it was found in some plant-derived antioxidants.
【0011】また、LDLを用いて試験した結果、同様
の結果を得るに至り、本発明を完成するに至った。Further, as a result of a test using LDL, similar results were obtained, and the present invention was completed.
【0012】即ち、本発明の課題を解決するための手段
は下記の通りである。That is, means for solving the problems of the present invention are as follows.
【0013】第1に、ペルオキシナイトライトによる蛋
白質の傷害抑制作用を有する、植物由来の抗酸化物質。
第2に、ペルオキシナイトライトによる蛋白質の傷害抑
制作用を有する、とうもろこし由来の抗酸化物質。第3
に、ペルオキシナイトライトによる蛋白質の傷害抑制作
用を有する、コーヒー豆由来の抗酸化物質。第4に、ペ
ルオキシナイトライトによる蛋白質の傷害抑制作用を有
する、ブドウ由来の抗酸化物質。First, a plant-derived antioxidant having a peroxynitrite inhibitory action on proteins.
Second, a corn-derived antioxidant having a peroxynitrite inhibitory effect on protein damage. Third
And an antioxidant derived from coffee beans, which has an action of inhibiting protein damage caused by peroxynitrite. Fourth, a grape-derived antioxidant having a protein damage inhibitory action by peroxynitrite.
【0014】第5に、下記の式に表された、ペルオキシ
ナイトライトによる蛋白質の傷害抑制作用を有する、植
物由来の抗酸化物質。Fifthly, a plant-derived antioxidant represented by the following formula and having a protein damage inhibitory action by peroxynitrite.
【0015】[0015]
【化4】 Embedded image
【0016】(式中、R1は水素原子、水酸基又はメト
キシル基を示し、且つR2は水酸基を示し、且つR3は水
素原子を示すか、あるいは、R1は水酸基を示し、且つ
R2はメトキシル基を示し、且つR3は水素原子を示す
か、あるいは、R1及びR3はメトキシル基を示し、且つ
R2は水酸基を示す。)[0016] (wherein, R 1 represents a hydrogen atom, a hydroxyl group or a methoxyl group, and R 2 represents a hydroxyl group, and either R 3 represents a hydrogen atom, or, R 1 is a hydroxyl group, and R 2 Represents a methoxyl group and R 3 represents a hydrogen atom, or R 1 and R 3 represent a methoxyl group and R 2 represents a hydroxyl group.)
【0017】即ち、上記式で表される物質は、まとめる
と、表1に記載のとおりである。That is, the substances represented by the above formula are summarized in Table 1 below.
【0018】[0018]
【表1】 [Table 1]
【0019】第6に、下記の式に表された、ペルオキシ
ナイトライトによる蛋白質の傷害抑制作用を有する、植
物由来の抗酸化物質。Sixth, a plant-derived antioxidant represented by the following formula and having an inhibitory action on protein damage by peroxynitrite.
【0020】[0020]
【化5】 Embedded image
【0021】(式中、R1及びR3はメトキシル基を示
し、且つR2は水酸基を示すか、あるいは、R1は水素原
子又はメトキシル基を示し、且つR2は水酸基を示し、
且つR3は水素原子を示すか、あるいは、R1は水酸基を
示し、且つR2はメトキシル基を示し、且つR3は水素原
子を示す。)Wherein R 1 and R 3 represent a methoxyl group and R 2 represents a hydroxyl group, or R 1 represents a hydrogen atom or a methoxyl group, and R 2 represents a hydroxyl group;
And R 3 represents a hydrogen atom, or R 1 represents a hydroxyl group, R 2 represents a methoxyl group, and R 3 represents a hydrogen atom. )
【0022】即ち、上記式で表される物質は、まとめる
と、表2に記載のとおりである。That is, the substances represented by the above formula are summarized as shown in Table 2.
【0023】[0023]
【表2】 [Table 2]
【0024】第7に、下記の式に表された、ペルオキシ
ナイトライトによる蛋白質の傷害抑制作用を有する、植
物由来の抗酸化物質。Seventh, a plant-derived antioxidant represented by the following formula and having an inhibitory action on protein damage by peroxynitrite.
【0025】[0025]
【化6】 Embedded image
【0026】(式中、R1及びR3は水酸基を示し、且つ
R2は水素原子を示すか、あるいは、R1は水酸基を示
し、且つR2はメトキシル基を示し、且つR3はカルボキ
シル基を示す。)Wherein R 1 and R 3 represent a hydroxyl group and R 2 represents a hydrogen atom, or R 1 represents a hydroxyl group and R 2 represents a methoxyl group, and R 3 represents a carboxyl group. Represents a group.)
【0027】即ち、上記式で表される物質は、まとめる
と、表3に記載のとおりである。That is, the substances represented by the above formula are summarized as shown in Table 3.
【0028】[0028]
【表3】 [Table 3]
【0029】第8に、ペルオキシナイトライトによる蛋
白質の傷害抑制作用を有する植物を、10〜99%アル
コール水溶液で抽出することで製造する、植物由来の抗
酸化物質の製造方法。第9に、ペルオキシナイトライト
による蛋白質の傷害抑制作用を有するとうもろこし由来
のグルテンミール(GM)を、50〜80%アルコール
水溶液で抽出することで製造する、とうもろこし由来の
抗酸化物質の製造方法。第10に、ペルオキシナイトラ
イトによる蛋白質の傷害抑制作用を有するコーヒー豆
を、60〜99%アルコール水溶液で抽出することで製
造する、コーヒー豆由来の抗酸化物質の製造方法。第1
1に、ペルオキシナイトライトによる蛋白質の傷害抑制
作用を有するブドウを、10〜50%アルコール水溶液
で抽出することで製造する、ブドウ由来の抗酸化物質の
製造方法。Eighth, a method for producing a plant-derived antioxidant, which comprises producing a plant having an inhibitory effect on protein damage by peroxynitrite by extracting it with an aqueous solution of 10-99% alcohol. Ninth, a method for producing a corn-derived antioxidant, which comprises producing corn-derived gluten meal (GM) having a protein damage inhibitory action by peroxynitrite by extracting it with a 50 to 80% aqueous alcohol solution. Tenth, a method for producing an antioxidant derived from coffee beans, which comprises producing coffee beans having a protein-injury inhibitory action by peroxynitrite with a 60-99% alcohol aqueous solution. First
1. A method for producing a grape-derived antioxidant, which comprises producing a grape having a protein damage inhibitory action by peroxynitrite by extracting it with a 10 to 50% alcohol aqueous solution.
【0030】[0030]
【実施例1】Embodiment 1
【0031】とうもろこしからコーンスターチ製造にお
いて副産物として生じるコーンスティープリカー(CS
L)100gを、3倍量の飽和食塩水(300ml)で
希釈したものを、100ml酢酸エチルと攪拌後、遠心
分離(3500rpm,15min.)を行い、液・液
分配を3回繰り返し行うことで、酢酸エチル抽出物を得
た。Corn steep liquor (CS) produced as a by-product in the production of corn starch from corn
L) 100 g was diluted with a three-fold amount of saturated saline (300 ml), stirred with 100 ml of ethyl acetate, centrifuged (3500 rpm, 15 min.), And liquid-liquid distribution was repeated three times. Thus, an ethyl acetate extract was obtained.
【0032】この酢酸エチル抽出物を、飽和炭酸水素ナ
トリウム溶液100mlで抽出後、1N塩酸でpHを酸
性とした後、100mlの酢酸エチルで3回抽出し、酢
酸エチル可溶画分を得た。The ethyl acetate extract was extracted with 100 ml of saturated sodium hydrogen carbonate solution, acidified with 1N hydrochloric acid, and then extracted three times with 100 ml of ethyl acetate to obtain a fraction soluble in ethyl acetate.
【0033】この酢酸エチル可溶画分を、水および飽和
食塩水により軽く洗浄した後、無水硫酸ナトリウムを添
加し、脱水を行ない、ろ過し、減圧下溶媒留去し、粗抽
出物280mgを得た。After the ethyl acetate-soluble fraction was washed lightly with water and saturated saline, anhydrous sodium sulfate was added thereto, followed by dehydration, filtration and evaporation under reduced pressure to obtain 280 mg of a crude extract. Was.
【0034】この粗抽出物を、後述の大澤ら(J.Ag
ric.Food.Chem.,35,808(198
7))により開発された兎赤血球膜ゴーストを用いた抗
酸化試験を指標に、常法に従い、シリカゲルカラムクロ
マトグラフ(i.d.20×250mm、eluen
t;n−Hex.:EtOAc=1:2)、分取HPL
C(column Wakosil−II5C18 i.
d.20×250mm、eluent;30%MeO
H,0.1%TFA,flow;5.0ml/mi
n.,detc;UV254nm)といった手法を用い
て、精製・単離し、活性物質0.9mgを得た。This crude extract was prepared by the method described in Osawa et al.
ric. Food. Chem. , 35, 808 (198
Using a rabbit erythrocyte membrane ghost developed by 7)) as an index, a silica gel column chromatograph (id 20 × 250 mm, eluen) is used according to a conventional method.
t; n-Hex. : EtOAc = 1: 2), preparative HPL
C (column Wakosil-II5C18 i.
d. 20 x 250 mm, eluent; 30% MeO
H, 0.1% TFA, flow; 5.0 ml / mi
n. , Detc; UV254 nm) to obtain 0.9 mg of the active substance.
【0035】該活性物質を、1H−NMR,EI−MS
を始めとする機器分析により構造解析を行ったところ、
シナピン酸のスペクトルと完全に一致した。The active substance was analyzed by 1 H-NMR, EI-MS
When structural analysis was performed by instrumental analysis including
It was completely consistent with the spectrum of sinapinic acid.
【0036】また、他にも、上記で得た粗抽出物から、
シリカゲルカラムクロマトグラフ、分取TLC、分取H
PLCといった手法を用いて、精製・単離し、構造解析
を行ったところ、シナピン酸と共に、次に示す物質が含
有されていることが明らかになった。In addition, from the crude extract obtained above,
Silica gel column chromatography, preparative TLC, preparative H
Purification, isolation, and structural analysis using a technique such as PLC revealed that the following substances were contained together with sinapic acid.
【0037】[0037]
【化7】 Embedded image
【0038】なお、上記式において表された物質は前記
表1に示されたとおりである。The substances represented by the above formula are as shown in Table 1 above.
【0039】[0039]
【化8】 Embedded image
【0040】なお、上記式において表された物質は前記
表2に示されたとおりである。The substances represented by the above formula are as shown in Table 2 above.
【0041】[0041]
【化9】 Embedded image
【0042】なお、上記式において表された物質は前記
表3に示されたとおりである。The substances represented by the above formulas are as shown in Table 3 above.
【0043】[0043]
【試験例1】[Test Example 1]
【0044】上記実施例1で精製した各物質について、
従来から抗酸化物質として使われているトコフェロー
ル、アスコルビン酸と同様に、食品の酸化防止や化粧品
の美白作用について満足できる程度の効果を有するか否
かについて、大澤ら(J.Agric.Food.Ch
em.,35,808(1987))により開発された
兎赤血球膜ゴーストを用いた抗酸化試験により、酸化阻
害率を求めることで抗酸化活性を調べた。For each substance purified in Example 1 above,
Similar to tocopherol and ascorbic acid, which have been conventionally used as antioxidants, whether or not they have a satisfactory effect on the prevention of food oxidation and the whitening effect of cosmetics, Osawa et al. (J. Agric. Food. Ch.
em. , 35, 808 (1987)), the antioxidant activity was determined by determining the oxidation inhibition rate using an antioxidant test using a rabbit erythrocyte membrane ghost.
【0045】また、上記実施例1で精製した各物質につ
いて、生体における活性酸素による酸化傷害に対して
も、十分な抑制効果を有するか否かを調べるために、加
藤ら(J.Agric.Food.Chem.,45,
3007 (1997))により開発されたELISA
を用いた蛋白質のペルオキシナイトライトによる傷害抑
制試験を行った。Further, in order to examine whether or not each substance purified in Example 1 has a sufficient inhibitory effect on oxidative damage caused by active oxygen in a living body, Kato et al. (J. Agric. Food) Chem., 45,
3007 (1997))
A peroxynitrite injury inhibition test was performed on the protein using the above method.
【0046】(1)抗酸化試験(1) Antioxidant test
【0047】兎赤血球膜ゴーストを用いた抗酸化試験
は、基本的に大澤らにより開発された兎赤血球膜ゴース
トを用いた抗酸化試験(J.Agric.Food.C
hem.,35,808(1987))に従って、各物
質及び比較のためのトコフェロール(tocopherol)を用
いて、次のように行った。まず、兎保存血より得られる
赤血球膜ゴースト0.5mlに対し、各物質のサンプル
のメタノール溶液(1.0mg/ml)100μlを添
加し、軽く攪拌した後、24mMのt-butylhy
droperoxide溶液50μlを添加し、37℃
で20分間インキュベートした。反応終了後、2.0M
トリクロロ酢酸−1.7M塩酸溶液と、0.67%チオ
バルビツール酸の1:2混合溶液を、3ml加え攪拌
後、沸騰水中15分間加熱して発色させた。氷冷後、3
500rpmで遠心分離を行い、その上清の532nm
における吸光度を測定することで、酸化阻害率を求め
た。その結果を、図1に示す。図1によると、実施例1
で得られた物質のうち、一部の物質が、トコフェロール
と比べ強い活性を示すことが確認された。The antioxidant test using a rabbit erythrocyte membrane ghost is basically an antioxidant test using a rabbit erythrocyte membrane ghost developed by Osawa et al. (J. Agric. Food. C).
hem. , 35, 808 (1987)) using each substance and tocopherol for comparison as follows. First, 100 μl of a methanol solution (1.0 mg / ml) of a sample of each substance was added to 0.5 ml of erythrocyte membrane ghost obtained from stored rabbit blood, and the mixture was gently stirred, and then 24 mM t-butylylhyd.
Add 50 μl of droperoxide solution, and add
For 20 minutes. After the reaction, 2.0M
3 ml of a 1: 2 mixed solution of trichloroacetic acid-1.7M hydrochloric acid solution and 0.67% thiobarbituric acid was added, stirred, and heated for 15 minutes in boiling water to develop color. After ice cooling, 3
Centrifuge at 500 rpm, and discard the supernatant at 532 nm.
The oxidation inhibition rate was determined by measuring the absorbance at. The result is shown in FIG. According to FIG.
It was confirmed that among the substances obtained in the above, some of the substances showed stronger activity than tocopherol.
【0048】(2)傷害抑制試験(2) Injury suppression test
【0049】傷害抑制試験は、加藤らにより開発された
ELISAを用いた蛋白質のペルオキシナイトライトに
よる傷害抑制試験(J.Agric.Food.Che
m.,45,3007(1997))に従って、各物質
について、次のように試験を行った。なお、傷害抑制試
験には、基質蛋白質として皮膚の下部において保湿等の
役割を果たすコラーゲン、および動脈硬化との関連が指
摘されるLDLを用いたが、蛋白質で有れば特に制限は
ない。まず、0.1Mリン酸緩衝液(pH7.4)90
μlにコラーゲンを最終濃度0.5mg/mlとなるよ
う溶解した。次いで、等濃度(mol%)の各種抗酸化物
質のDMSO溶液10μlを添加し、最終濃度1.0m
M量のペルオキシナイトライトを反応させ、生じるニト
ロチロシン部位をELISAを用いて測定した。その結
果、図2に示すように、トコフェロール、アスコルビン
酸、BHAは、活性がほとんど見られないのに対し、上
記CSLに含まれる大多数の物質において、顕著な活性
が見られた。また、同様に動脈硬化との関連が指摘され
ているLDL1.0mg/mlを基質として用いた場合
にも、図3に示すように、同様な結果が得られた。The injury inhibition test was carried out using a peroxynitrite injury inhibition test (J. Agric. Food. Che) using ELISA developed by Kato et al.
m. , 45, 3007 (1997)). In the injury suppression test, collagen which plays a role of moisturizing and the like in the lower part of the skin as a substrate protein and LDL which is pointed out to be associated with arteriosclerosis were used, but there is no particular limitation as long as it is a protein. First, a 0.1 M phosphate buffer (pH 7.4) 90
Collagen was dissolved in μl to a final concentration of 0.5 mg / ml. Next, 10 μl of a DMSO solution of various antioxidants at an equal concentration (mol%) was added, and a final concentration of 1.0 m
M amount of peroxynitrite was reacted, and the generated nitrotyrosine site was measured using ELISA. As a result, as shown in FIG. 2, tocopherol, ascorbic acid, and BHA showed almost no activity, whereas the majority of the substances contained in the CSL showed remarkable activity. Similarly, when LDL 1.0 mg / ml, which has been similarly linked to arteriosclerosis, was used as a substrate, similar results were obtained as shown in FIG.
【0050】[0050]
【実施例2】Embodiment 2
【0051】上記実施例1でCSLを用いる代わりに、
グルテンミール(GM)を用いる他は、次のように抽出
の際の条件を変えた以外は同様の条件で、抗酸化物質を
製造した。まず、水、水-エチルアルコール溶液および
ヘキサンを用いた抽出物の兎赤血球膜ゴーストを用いた
評価を行ったところ、50〜80%好ましくは50%エ
チルアルコール水溶液抽出物中に最も活性が見られた。
そこで、GM50gに対し、50,70,80%エチル
アルコール150mlを、それぞれ500mlの三角フ
ラスコに入れ、シェーカーを用いて室温で2時間抽出を
行った後、ろ過および減圧下溶媒留去し、各サンプルを
その抽出溶媒を用いて10および100mg/mlに調
製した。得られた調整物について、兎赤血球膜ゴースト
を用いた評価を行ったところ、表4に示すように、50
%および70%EtOH抽出物において強い活性が見ら
れた。Instead of using CSL in the first embodiment,
An antioxidant was produced under the same conditions except that gluten meal (GM) was used, except that the conditions for extraction were changed as follows. First, when an extract using water, a water-ethyl alcohol solution and hexane was evaluated using a rabbit erythrocyte membrane ghost, the most active was found in the 50-80%, preferably 50% ethyl alcohol aqueous solution extract. Was.
Therefore, 150 ml of 50, 70, and 80% ethyl alcohol was placed in a 500 ml Erlenmeyer flask with respect to 50 g of GM, extracted at room temperature for 2 hours using a shaker, and then filtered and the solvent was distilled off under reduced pressure. Was adjusted to 10 and 100 mg / ml using the extraction solvent. The obtained preparation was evaluated using a rabbit erythrocyte membrane ghost.
Strong activity was seen in the% and 70% EtOH extracts.
【0052】[0052]
【表4】 [Table 4]
【0053】[0053]
【実施例3】Embodiment 3
【0054】GM50%EtOH抽出物乾燥品を、50
%EtOHを用いて50.0mg/mlとなるよう溶解
した。この溶液2.0mlを、溶媒を水に置換した合成
吸着剤(HP20)を入れたカラム(i.d.19mm×2
50mm)にのせ、H2O,20および50%EtOH
それぞれ300mlにて順次溶出を行ない、各フラクシ
ョンの重量及び活性について測定したところ、表5に示
すように、50%EtOH溶出画分において強い活性が
見られた。The dried product of the GM 50% EtOH extract was
The solution was dissolved using 5% EtOH to a concentration of 50.0 mg / ml. A column (id 19 mm × 2) containing 2.0 ml of this solution and containing a synthetic adsorbent (HP20) in which the solvent was replaced with water was used.
Placed in 50mm), H 2 O, 20 and 50% EtOH
Elution was performed sequentially at 300 ml each, and the weight and activity of each fraction were measured. As shown in Table 5, strong activity was observed in the 50% EtOH elution fraction.
【0055】[0055]
【表5】 [Table 5]
【0056】[0056]
【実施例4】Embodiment 4
【0057】コーヒー抽出粕1.0gをフタ付き試験管
に取り、H2O,30%,60%,99%エチルアルコ
ール、n−ヘキサンの5種類の溶媒各5.0mlを添加
し、シェーカーにより室温において3時間抽出を行っ
た。この上清を用いて兎赤血球膜を用いた評価を行うと
ともに、その上清2.0mlを濃縮・乾固し重量の測定
を行ったところ、60%および99%エチルアルコール
抽出物に強い活性が認められた。その結果を、表6に示
す1.0 g of coffee extract cake is placed in a test tube with a lid, and 5.0 ml of each of five kinds of solvents of H 2 O, 30%, 60%, 99% ethyl alcohol and n-hexane are added, and the mixture is shaken with a shaker. Extraction was performed at room temperature for 3 hours. The supernatant was used for evaluation using a rabbit erythrocyte membrane, and 2.0 ml of the supernatant was concentrated and dried to measure the weight. As a result, a strong activity was found in the 60% and 99% ethyl alcohol extracts. Admitted. Table 6 shows the results.
【0058】[0058]
【表6】 [Table 6]
【0059】そこで、さらに、60,70,80,9
0,99%エチルアルコールを用いて、単位重量あたり
の活性を比較したところ、図4に示すように、60〜9
0%エチルアルコール抽出物にほぼ等しく強い活性が見
られた 。Then, 60, 70, 80, 9
When the activity per unit weight was compared using 0,99% ethyl alcohol, as shown in FIG.
Almost equally strong activity was seen in the 0% ethyl alcohol extract.
【0060】[0060]
【実施例5】Embodiment 5
【0061】本発明者らは、近年抗酸化食品素材として
注目されている赤ワインの原料であるブドウについても
検討を行った。すなわち、ブドウの抽出物の活性につい
て検討を行った結果、30〜50%エチルアルコール水
溶液抽出物に強い活性が見られた。その結果を表7に示
す。The present inventors have also studied grape, which is a raw material of red wine, which has recently attracted attention as an antioxidant food material. That is, as a result of examining the activity of the grape extract, a strong activity was found in the 30-50% ethyl alcohol aqueous solution extract. Table 7 shows the results.
【0062】[0062]
【表7】 [Table 7]
【0063】GM50%EtOH抽出物、コーヒー抽出
粕80%EtOH抽出物、及びぶどう40%EtOH抽
出物の兎赤血球膜ゴースト及びコラーゲンを基質とした
ペルオキシナイトライトに対する傷害抑制の同濃度(1
0mg/ml)における活性をトコフェロールと比較し
た。その結果を図5に示す。The same concentration of the GM 50% EtOH extract, coffee extract cake 80% EtOH extract, and grape 40% EtOH extract at the same concentration (1
0 mg / ml) was compared to tocopherol. The result is shown in FIG.
【0064】[0064]
【0065】本発明に係る抗酸化物質によると、従来か
ら抗酸化物質として使われているトコフェロール、アス
コルビン酸と同様に、食品の酸化防止等について満足で
きる程度の効果を有し、しかも、生体における活性酸素
による酸化傷害に対しても、十分な抑制効果を有する。According to the antioxidant according to the present invention, as with tocopherol and ascorbic acid which have been conventionally used as antioxidants, the antioxidant has a satisfactory effect on the prevention of oxidation of foods and the like, It also has a sufficient inhibitory effect on oxidative damage caused by active oxygen.
【図1】抗酸化試験の結果を示すグラフFIG. 1 is a graph showing the results of an antioxidant test.
【図2】コラーゲンを基質として用いた場合の傷害抑制
試験の結果を示すグラフFIG. 2 is a graph showing the results of an injury suppression test using collagen as a substrate.
【図3】LDLを基質として用いた場合の傷害抑制試験
の結果を示すグラフFIG. 3 is a graph showing the results of an injury suppression test using LDL as a substrate.
【図4】コーヒー抽出粕を各濃度のエチルアルコール溶
媒で抽出した場合の活性を示すグラフFIG. 4 is a graph showing the activity when coffee extract cake is extracted with ethyl alcohol solvents at various concentrations.
【図5】ペルオキシナイトライト傷害抑制及び兎赤血球
膜ゴースト傷害抑制の阻害率を表すグラフFIG. 5 is a graph showing the inhibition rates of peroxynitrite injury suppression and rabbit erythrocyte membrane ghost injury suppression.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C09K 15/06 C09K 15/06 15/08 15/08 // A23L 3/3508 A23L 3/3508 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI C09K 15/06 C09K 15/06 15/08 15/08 // A23L 3/3508 A23L 3/3508
Claims (11)
傷害抑制作用を有する、植物由来の抗酸化物質。1. A plant-derived antioxidant which has an inhibitory action on protein damage by peroxynitrite.
傷害抑制作用を有する、とうもろこし由来の抗酸化物
質。2. An antioxidant derived from corn, which has an inhibitory effect on protein damage by peroxynitrite.
傷害抑制作用を有する、コーヒー豆由来の抗酸化物質。3. An antioxidant derived from coffee beans, which has an effect of inhibiting protein damage caused by peroxynitrite.
傷害抑制作用を有する、ブドウ由来の抗酸化物質。4. A grape-derived antioxidant having an inhibitory effect on protein damage by peroxynitrite.
ライトによる蛋白質の傷害抑制作用を有する、植物由来
の抗酸化物質。 【化1】 (式中、R1は水素原子、水酸基又はメトキシル基を示
し、且つR2は水酸基を示し、且つR3は水素原子を示す
か、あるいは、R1は水酸基を示し、且つR2はメトキシ
ル基を示し、且つR3は水素原子を示すか、あるいは、
R1及びR3はメトキシル基を示し、且つR2は水酸基を
示す。)5. A plant-derived antioxidant represented by the following formula and having an inhibitory action on protein damage by peroxynitrite. Embedded image (Wherein, R 1 represents a hydrogen atom, a hydroxyl group or a methoxyl group, and R 2 represents a hydroxyl group and R 3 represents a hydrogen atom, or R 1 represents a hydroxyl group, and R 2 represents a methoxyl group. And R 3 represents a hydrogen atom, or
R 1 and R 3 represent a methoxyl group, and R 2 represents a hydroxyl group. )
ライトによる蛋白質の傷害抑制作用を有する、植物由来
の抗酸化物質。 【化2】 (式中、R1及びR3はメトキシル基を示し、且つR2は
水酸基を示すか、あるいは、R1は水素原子又はメトキ
シル基を示し、且つR2は水酸基を示し、且つR3は水素
原子を示すか、あるいは、R1は水酸基を示し、且つR2
はメトキシル基を示し、且つR3は水素原子を示す。)6. A plant-derived antioxidant represented by the following formula and having an inhibitory action on protein damage by peroxynitrite. Embedded image (Wherein R 1 and R 3 represent a methoxyl group and R 2 represents a hydroxyl group, or R 1 represents a hydrogen atom or a methoxyl group, and R 2 represents a hydroxyl group, and R 3 represents a hydrogen group. Represents an atom, or R 1 represents a hydroxyl group and R 2
Represents a methoxyl group, and R 3 represents a hydrogen atom. )
ライトによる蛋白質の傷害抑制作用を有する、植物由来
の抗酸化物質。 【化3】 (式中、R1及びR3は水酸基を示し、且つR2は水素原
子を示すか、あるいは、R1は水酸基を示し、且つR2は
メトキシル基を示し、且つR3はカルボキシル基を示
す。)7. A plant-derived antioxidant represented by the following formula and having an inhibitory action on protein damage by peroxynitrite. Embedded image (Wherein R 1 and R 3 represent a hydroxyl group and R 2 represents a hydrogen atom, or R 1 represents a hydroxyl group and R 2 represents a methoxyl group, and R 3 represents a carboxyl group. .)
傷害抑制作用を有する植物を、10〜99%アルコール
水溶液で抽出することで製造する、植物由来の抗酸化物
質の製造方法。8. A method for producing a plant-derived antioxidant, which comprises producing a plant having an inhibitory action on protein damage by peroxynitrite by extracting the plant with a 10-99% aqueous alcohol solution.
傷害抑制作用を有するとうもろこし由来のグルテンミー
ル(GM)を、50〜80%アルコール水溶液で抽出す
ることで製造する、とうもろこし由来の抗酸化物質の製
造方法。9. A method for producing a corn-derived antioxidant, which comprises producing corn-derived gluten meal (GM) having a protein damage inhibitory action by peroxynitrite by extracting it with a 50-80% aqueous alcohol solution.
の傷害抑制作用を有するコーヒー豆を、60〜99%ア
ルコール水溶液で抽出することで製造する、コーヒー豆
由来の抗酸化物質の製造方法。10. A method for producing an antioxidant derived from coffee beans, comprising extracting coffee beans having a protein damage inhibitory action by peroxynitrite with a 60-99% aqueous alcohol solution.
の傷害抑制作用を有するブドウを、10〜50%アルコ
ール水溶液で抽出することで製造する、ブドウ由来の抗
酸化物質の製造方法。11. A method for producing a grape-derived antioxidant, which comprises producing a grape having a protein damage inhibitory action by peroxynitrite by extracting it with a 10 to 50% alcohol aqueous solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9350215A JPH11172246A (en) | 1997-12-05 | 1997-12-05 | Anti-oxidant and manufacture thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9350215A JPH11172246A (en) | 1997-12-05 | 1997-12-05 | Anti-oxidant and manufacture thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11172246A true JPH11172246A (en) | 1999-06-29 |
Family
ID=18409003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9350215A Pending JPH11172246A (en) | 1997-12-05 | 1997-12-05 | Anti-oxidant and manufacture thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11172246A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002265387A (en) * | 2001-03-06 | 2002-09-18 | Kose Corp | Skin care preparation |
| WO2002074300A1 (en) * | 2001-03-07 | 2002-09-26 | Dong Wha Pharm. Ind. Co., Ltd. | Composition for treating arteriosclerosis comprising 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid or its derivatives |
| JP2002326922A (en) * | 2001-03-01 | 2002-11-15 | Kose Corp | Skin external preparation |
| JP2003095976A (en) * | 2001-09-21 | 2003-04-03 | Tamanoi Vineger Co Ltd | Antioxidant composition, prophylactic against carcinogenesis and composition separated from vinegar |
| JP2018080206A (en) * | 2014-10-21 | 2018-05-24 | 丸善製薬株式会社 | Skin cosmetic, hair cosmetic and food or drink |
-
1997
- 1997-12-05 JP JP9350215A patent/JPH11172246A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002326922A (en) * | 2001-03-01 | 2002-11-15 | Kose Corp | Skin external preparation |
| JP2002265387A (en) * | 2001-03-06 | 2002-09-18 | Kose Corp | Skin care preparation |
| WO2002074300A1 (en) * | 2001-03-07 | 2002-09-26 | Dong Wha Pharm. Ind. Co., Ltd. | Composition for treating arteriosclerosis comprising 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid or its derivatives |
| JP2003095976A (en) * | 2001-09-21 | 2003-04-03 | Tamanoi Vineger Co Ltd | Antioxidant composition, prophylactic against carcinogenesis and composition separated from vinegar |
| JP2018080206A (en) * | 2014-10-21 | 2018-05-24 | 丸善製薬株式会社 | Skin cosmetic, hair cosmetic and food or drink |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH679584A5 (en) | ||
| JPH092917A (en) | Polyphenol preparation obtained from hops and its manufacturing method | |
| AU2003289233B2 (en) | Whitening agent, skin preparation for external use and cosmetic | |
| JP4142859B2 (en) | Fruit polyphenols, antioxidants, antihypertensives, antimutagenic agents, allergy inhibitors, anti-cariogenic agents and deodorants | |
| JP4268896B2 (en) | Flavanone compound, method for producing the same, and antioxidant | |
| JPH1179936A (en) | Whitening cosmetics containing marvelin | |
| JPH08319433A (en) | Apple red pigment and its manufacturing method, antioxidant, antihypertensive agent, allergy suppressant, anticaries agent and deodorant | |
| JPH11172246A (en) | Anti-oxidant and manufacture thereof | |
| KR101283849B1 (en) | Novel cosmetic composition having antioxidant activity and skin-whitening effect | |
| JP3060051B2 (en) | Pyridine derivative and fragrance composition containing the derivative | |
| US7074907B2 (en) | Compound, process for producing the same and use thereof | |
| JP2715375B2 (en) | Sesaminol glycoside and water-soluble antioxidant | |
| JP2001302659A (en) | New material isolated from ecklonia cava, method for extraction and purification of the same, method for using the same as antioxidant | |
| JP3001531B1 (en) | Tobacco flavor enhancer and tobacco products containing it | |
| JPH11246426A (en) | Hyperlipidemia therapeutic agent and food composition containing the same | |
| JP3390420B2 (en) | Novel substance isolated from squid, its extraction and purification method, and its use as an antioxidant | |
| JP3039864B1 (en) | Tricaffeoyl aldaric acid, its production method and its use | |
| JP4149836B2 (en) | Dihydroxybenzoate derivative, process for producing the same and use thereof | |
| JP2663393B2 (en) | Pinoresinol glycoside and method for preventing lipid oxidation using the same | |
| JP4061877B2 (en) | Method for producing antioxidant | |
| JPH111686A (en) | Antioxidant | |
| JP3514403B2 (en) | 1-β-O- (4-formylphenyl) -4-O- [3- (3,4-dihydroxyphenyl) propenoyl] -D-glucopyranoside | |
| KR20120037279A (en) | A method for separating and purifying cosmetic effective compounds comprising p-coumaric acid from sasa querlpaertensis nakai | |
| JP2008061507A (en) | Meat odor improving agent, meat odor improving method using the same, and meat product | |
| JP3670609B2 (en) | Antioxidants containing soybean saponins derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041122 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20041122 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041206 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041122 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070112 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070530 |